Résultats de la recherche - 4 results

How robust is ACTIVLIM for the follow-up of activity limitations in patients with neuromuscular diseases?

Publication Type: Peer reviewed scientific article Authors: Batcho, Sèbiyo; Van den Bergh, Peter Y.K.; Van Damme, Philip; Roy, Anna J.; Thonnard, Jean-Louis; Penta, Massimo Source: Neuromuscular ...

Early stages of building a rare disease registry, methods and 2010 data from the Belgian Neuromuscular Disease Registry (BNMDR).

prevalence in Belgium is five times lower: 6.5 per 100,000 in the north of Belgium, versus 17.0-41.0 per 100,000 in other areas of Europe. Very few patients were captured in the south of the country. With the ...

The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations

Chan,S.; Korngut,L.; Campbell,C.; Dai,Y.; Wang,J.; Barisic,N.; Brabec,P.; Lahdetie,J.; Walter,M.C.; O. Schreiber-Katz; Karcagi,V.; Garami,M.; Viswanathan,V.; Bayat,F.; Buccella,F.; Kimura,E.; Koeks,Z.; van ...

The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia

Rasic,V.M.; Posada,M.; Palau,F.; Lindvall,B.; Bloetzer,C.; A.A. Karaduman; Topaloglu,H.; Inal,S.; Oflazer,P.; Stringer,A.; Shatillo,A.V.; A.S. Martin; H.L. Peay; Flanigan,K.M.; Salgado,D.; von Rekowski,B.; ...

QR code

QR code for this page URL